EMEA (Europe, Middle East and Africa) Regenerative Medicine Market Report 2018

April 2018 | 111 pages | ID: ED4518A8A35EN
QYResearch

Abstracts

In this report, the EMEA Regenerative Medicine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Regenerative Medicine for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Regenerative Medicine market competition by top manufacturers/players, with Regenerative Medicine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Aastrom Biosciences Inc
• Advanced Cell Technology
• Athersys Inc
• Amgen Inc
• Bioheart Inc
• Cytori Therapeutics Inc
• Celgene Corporation
• Geron Corporation
• Genzyme Corporation
• Osiris Therapeutics Inc
• Japan Tissue Engineering Co
• Thermogenesis Corp
• Mesoblast, Inc
• Vertex Pharmaceuticals, Inc
• Organogenesis, Inc
• Nuvasive, Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Cell Therapy (Ct) Based Products
• Tissue Engineered (Te) Products
• Bone and Cartilage Grafting and Regenerative Products
• Electrical Stimulators
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Bone And Joints Replacement
• Dental
• Neurological
• Organ Regeneration
• Cardiovascular Disorders
• Wound Care
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Regenerative Medicine Market Report 2018

1 REGENERATIVE MEDICINE OVERVIEW

1.1 Product Overview and Scope of Regenerative Medicine
1.2 Classification of Regenerative Medicine
  1.2.1 EMEA Regenerative Medicine Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Regenerative Medicine Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Cell Therapy (Ct) Based Products
  1.2.4 Tissue Engineered (Te) Products
  1.2.5 Bone and Cartilage Grafting and Regenerative Products
  1.2.6 Electrical Stimulators
  1.2.7 Others
1.3 EMEA Regenerative Medicine Market by Application/End Users
  1.3.1 EMEA Regenerative Medicine Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Bone And Joints Replacement
  1.3.3 Dental
  1.3.4 Neurological
  1.3.5 Organ Regeneration
  1.3.6 Cardiovascular Disorders
  1.3.7 Wound Care
  1.3.8 Others
1.4 EMEA Regenerative Medicine Market by Region
  1.4.1 EMEA Regenerative Medicine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Regenerative Medicine (2013-2025)
  1.5.1 EMEA Regenerative Medicine Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Regenerative Medicine Revenue and Growth Rate (2013-2025)

2 EMEA REGENERATIVE MEDICINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Regenerative Medicine Market Competition by Players/Manufacturers
  2.1.1 EMEA Regenerative Medicine Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Regenerative Medicine Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Regenerative Medicine Sale Price by Players (2013-2018)
2.2 EMEA Regenerative Medicine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Regenerative Medicine Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Regenerative Medicine Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Regenerative Medicine Sale Price by Type (2013-2018)
2.3 EMEA Regenerative Medicine (Volume) by Application
2.4 EMEA Regenerative Medicine (Volume and Value) by Region
  2.4.1 EMEA Regenerative Medicine Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Regenerative Medicine Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Regenerative Medicine Sales Price by Region (2013-2018)

3 EUROPE REGENERATIVE MEDICINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Regenerative Medicine Sales and Value (2013-2018)
  3.1.1 Europe Regenerative Medicine Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Regenerative Medicine Revenue and Growth Rate (2013-2018)
3.2 Europe Regenerative Medicine Sales and Market Share by Type
3.3 Europe Regenerative Medicine Sales and Market Share by Application
3.4 Europe Regenerative Medicine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Regenerative Medicine Sales Volume by Countries (2013-2018)
  3.4.2 Europe Regenerative Medicine Revenue by Countries (2013-2018)
  3.4.3 Germany Regenerative Medicine Sales and Growth Rate (2013-2018)
  3.4.4 France Regenerative Medicine Sales and Growth Rate (2013-2018)
  3.4.5 UK Regenerative Medicine Sales and Growth Rate (2013-2018)
  3.4.6 Russia Regenerative Medicine Sales and Growth Rate (2013-2018)
  3.4.7 Italy Regenerative Medicine Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Regenerative Medicine Sales and Growth Rate (2013-2018)

4 MIDDLE EAST REGENERATIVE MEDICINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Regenerative Medicine Sales and Value (2013-2018)
  4.1.1 Middle East Regenerative Medicine Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Regenerative Medicine Revenue and Growth Rate (2013-2018)
4.2 Middle East Regenerative Medicine Sales and Market Share by Type
4.3 Middle East Regenerative Medicine Sales and Market Share by Application
4.4 Middle East Regenerative Medicine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Regenerative Medicine Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Regenerative Medicine Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Regenerative Medicine Sales and Growth Rate (2013-2018)
  4.4.4 Israel Regenerative Medicine Sales and Growth Rate (2013-2018)
  4.4.5 UAE Regenerative Medicine Sales and Growth Rate (2013-2018)
  4.4.6 Iran Regenerative Medicine Sales and Growth Rate (2013-2018)

5 AFRICA REGENERATIVE MEDICINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Regenerative Medicine Sales and Value (2013-2018)
  5.1.1 Africa Regenerative Medicine Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Regenerative Medicine Revenue and Growth Rate (2013-2018)
5.2 Africa Regenerative Medicine Sales and Market Share by Type
5.3 Africa Regenerative Medicine Sales and Market Share by Application
5.4 Africa Regenerative Medicine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Regenerative Medicine Sales Volume by Countries (2013-2018)
  5.4.2 Africa Regenerative Medicine Revenue by Countries (2013-2018)
  5.4.3 South Africa Regenerative Medicine Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Regenerative Medicine Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Regenerative Medicine Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Regenerative Medicine Sales and Growth Rate (2013-2018)

6 EMEA REGENERATIVE MEDICINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Aastrom Biosciences Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Regenerative Medicine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aastrom Biosciences Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Advanced Cell Technology
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Regenerative Medicine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Advanced Cell Technology Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Athersys Inc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Regenerative Medicine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Athersys Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Amgen Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Regenerative Medicine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Bioheart Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Regenerative Medicine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bioheart Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Cytori Therapeutics Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Regenerative Medicine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Cytori Therapeutics Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Celgene Corporation
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Regenerative Medicine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Celgene Corporation Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Geron Corporation
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Regenerative Medicine Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Geron Corporation Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Genzyme Corporation
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Regenerative Medicine Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Genzyme Corporation Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Osiris Therapeutics Inc
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Regenerative Medicine Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Osiris Therapeutics Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Japan Tissue Engineering Co
6.12 Thermogenesis Corp
6.13 Mesoblast, Inc
6.14 Vertex Pharmaceuticals, Inc
6.15 Organogenesis, Inc
6.16 Nuvasive, Inc

7 REGENERATIVE MEDICINE MANUFACTURING COST ANALYSIS

7.1 Regenerative Medicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Regenerative Medicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Regenerative Medicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Regenerative Medicine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA REGENERATIVE MEDICINE MARKET FORECAST (2018-2025)

11.1 EMEA Regenerative Medicine Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Regenerative Medicine Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Regenerative Medicine Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Regenerative Medicine Price and Trend Forecast (2018-2025)
11.2 EMEA Regenerative Medicine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Regenerative Medicine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Regenerative Medicine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Regenerative Medicine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Regenerative Medicine Sales Forecast by Type (2018-2025)
11.7 EMEA Regenerative Medicine Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Regenerative Medicine
Figure EMEA Regenerative Medicine Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Regenerative Medicine Sales Volume Market Share by Type (Product Category) in 2017
Figure Cell Therapy (Ct) Based Products Product Picture
Figure Tissue Engineered (Te) Products Product Picture
Figure Bone and Cartilage Grafting and Regenerative Products Product Picture
Figure Electrical Stimulators Product Picture
Figure Others Product Picture
Figure EMEA Regenerative Medicine Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Regenerative Medicine by Application in 2017
Figure Bone And Joints Replacement Examples
Table Key Downstream Customer in Bone And Joints Replacement
Figure Dental Examples
Table Key Downstream Customer in Dental
Figure Neurological Examples
Table Key Downstream Customer in Neurological
Figure Organ Regeneration Examples
Table Key Downstream Customer in Organ Regeneration
Figure Cardiovascular Disorders Examples
Table Key Downstream Customer in Cardiovascular Disorders
Figure Wound Care Examples
Table Key Downstream Customer in Wound Care
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Regenerative Medicine Market Size (Million USD) by Region (2013-2025)
Figure Europe Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Regenerative Medicine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Regenerative Medicine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Regenerative Medicine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Regenerative Medicine Sales Volume and Growth Rate (2013-2025)
Figure EMEA Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Regenerative Medicine Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Regenerative Medicine Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Regenerative Medicine Sales Share by Players (2013-2018)
Figure 2017 Regenerative Medicine Sales Share by Players
Figure 2017 Regenerative Medicine Sales Share by Players
Figure EMEA Regenerative Medicine Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Regenerative Medicine Revenue (Million USD) by Players (2013-2018)
Table EMEA Regenerative Medicine Revenue Share by Players (2013-2018)
Table 2017 EMEA Regenerative Medicine Revenue Share by Players
Table 2017 EMEA Regenerative Medicine Revenue Share by Players
Table EMEA Regenerative Medicine Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Regenerative Medicine Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Regenerative Medicine Sales Share by Type (2013-2018)
Figure Sales Market Share of Regenerative Medicine by Type (2013-2018)
Figure EMEA Regenerative Medicine Sales Market Share by Type (2013-2018)
Table EMEA Regenerative Medicine Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Regenerative Medicine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Regenerative Medicine by Type in 2017
Table EMEA Regenerative Medicine Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Regenerative Medicine Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Regenerative Medicine Sales Share by Application (2013-2018)
Figure Sales Market Share of Regenerative Medicine by Application (2013-2018)
Figure EMEA Regenerative Medicine Sales Market Share by Application in 2017
Table EMEA Regenerative Medicine Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Regenerative Medicine Sales Share by Region (2013-2018)
Figure Sales Market Share of Regenerative Medicine by Region (2013-2018)
Figure EMEA Regenerative Medicine Sales Market Share in 2017
Table EMEA Regenerative Medicine Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Regenerative Medicine Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Regenerative Medicine by Region (2013-2018)
Figure EMEA Regenerative Medicine Revenue Market Share Regions in 2017
Table EMEA Regenerative Medicine Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Regenerative Medicine Revenue and Growth Rate (2013-2018)
Table Europe Regenerative Medicine Sales (K Units) by Type (2013-2018)
Table Europe Regenerative Medicine Market Share by Type (2013-2018)
Figure Europe Regenerative Medicine Market Share by Type in 2017
Table Europe Regenerative Medicine Sales (K Units) by Application (2013-2018)
Table Europe Regenerative Medicine Market Share by Application (2013-2018)
Figure Europe Regenerative Medicine Market Share by Application in 2017
Table Europe Regenerative Medicine Sales (K Units) by Countries (2013-2018)
Table Europe Regenerative Medicine Sales Market Share by Countries (2013-2018)
Figure Europe Regenerative Medicine Sales Market Share by Countries (2013-2018)
Figure Europe Regenerative Medicine Sales Market Share by Countries in 2017
Table Europe Regenerative Medicine Revenue (Million USD) by Countries (2013-2018)
Table Europe Regenerative Medicine Revenue Market Share by Countries (2013-2018)
Figure Europe Regenerative Medicine Revenue Market Share by Countries (2013-2018)
Figure Europe Regenerative Medicine Revenue Market Share by Countries in 2017
Figure Germany Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure France Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure UK Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Regenerative Medicine Sales (K Units) by Type (2013-2018)
Table Middle East Regenerative Medicine Market Share by Type (2013-2018)
Figure Middle East Regenerative Medicine Market Share by Type (2013-2018)
Table Middle East Regenerative Medicine Sales (K Units) by Applications (2013-2018)
Table Middle East Regenerative Medicine Market Share by Applications (2013-2018)
Figure Middle East Regenerative Medicine Sales Market Share by Application in 2017
Table Middle East Regenerative Medicine Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Regenerative Medicine Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Regenerative Medicine Sales Volume Market Share by Countries in 2017
Table Middle East Regenerative Medicine Revenue (Million USD) by Countries (2013-2018)
Table Middle East Regenerative Medicine Revenue Market Share by Countries (2013-2018)
Figure Middle East Regenerative Medicine Revenue Market Share by Countries (2013-2018)
Figure Middle East Regenerative Medicine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Regenerative Medicine Sales (K Units) by Type (2013-2018)
Table Africa Regenerative Medicine Sales Market Share by Type (2013-2018)
Figure Africa Regenerative Medicine Sales Market Share by Type (2013-2018)
Figure Africa Regenerative Medicine Sales Market Share by Type in 2017
Table Africa Regenerative Medicine Sales (K Units) by Application (2013-2018)
Table Africa Regenerative Medicine Sales Market Share by Application (2013-2018)
Figure Africa Regenerative Medicine Sales Market Share by Application (2013-2018)
Table Africa Regenerative Medicine Sales Volume (K Units) by Countries (2013-2018)
Table Africa Regenerative Medicine Sales Market Share by Countries (2013-2018)
Figure Africa Regenerative Medicine Sales Market Share by Countries (2013-2018)
Figure Africa Regenerative Medicine Sales Market Share by Countries in 2017
Table Africa Regenerative Medicine Revenue (Million USD) by Countries (2013-2018)
Table Africa Regenerative Medicine Revenue Market Share by Countries (2013-2018)
Figure Africa Regenerative Medicine Revenue Market Share by Countries (2013-2018)
Figure Africa Regenerative Medicine Revenue Market Share by Countries in 2017
Figure South Africa Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Table Aastrom Biosciences Inc Regenerative Medicine Basic Information List
Table Aastrom Biosciences Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aastrom Biosciences Inc Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Aastrom Biosciences Inc Regenerative Medicine Sales Market Share in EMEA (2013-2018)
Figure Aastrom Biosciences Inc Regenerative Medicine Revenue Market Share in EMEA (2013-2018)
Table Advanced Cell Technology Regenerative Medicine Basic Information List
Table Advanced Cell Technology Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Advanced Cell Technology Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Advanced Cell Technology Regenerative Medicine Sales Market Share in EMEA (2013-2018)
Figure Advanced Cell Technology Regenerative Medicine Revenue Market Share in EMEA (2013-2018)
Table Athersys Inc Regenerative Medicine Basic Information List
Table Athersys Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Athersys Inc Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Athersys Inc Regenerative Medicine Sales Market Share in EMEA (2013-2018)
Figure Athersys Inc Regenerative Medicine Revenue Market Share in EMEA (2013-2018)
Table Amgen Inc Regenerative Medicine Basic Information List
Table Amgen Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Inc Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Amgen Inc Regenerative Medicine Sales Market Share in EMEA (2013-2018)
Figure Amgen Inc Regenerative Medicine Revenue Market Share in EMEA (2013-2018)
Table Bioheart Inc Regenerative Medicine Basic Information List
Table Bioheart Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bioheart Inc Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Bioheart Inc Regenerative Medicine Sales Market Share in EMEA (2013-2018)
Figure Bioheart Inc Regenerative Medicine Revenue Market Share in EMEA (2013-2018)
Table Cytori Therapeutics Inc Regenerative Medicine Basic Information List
Table Cytori Therapeutics Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cytori Therapeutics Inc Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Cytori Therapeutics Inc Regenerative Medicine Sales Market Share in EMEA (2013-2018)
Figure Cytori Therapeutics Inc Regenerative Medicine Revenue Market Share in EMEA (2013-2018)
Table Celgene Corporation Regenerative Medicine Basic Information List
Table Celgene Corporation Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celgene Corporation Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Celgene Corporation Regenerative Medicine Sales Market Share in EMEA (2013-2018)
Figure Celgene Corporation Regenerative Medicine Revenue Market Share in EMEA (2013-2018)
Table Geron Corporation Regenerative Medicine Basic Information List
Table Geron Corporation Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Geron Corporation Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Geron Corporation Regenerative Medicine Sales Market Share in EMEA (2013-2018)
Figure Geron Corporation Regenerative Medicine Revenue Market Share in EMEA (2013-2018)
Table Genzyme Corporation Regenerative Medicine Basic Information List
Table Genzyme Corporation Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Genzyme Corporation Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Genzyme Corporation Regenerative Medicine Sales Market Share in EMEA (2013-2018)
Figure Genzyme Corporation Regenerative Medicine Revenue Market Share in EMEA (2013-2018)
Table Osiris Therapeutics Inc Regenerative Medicine Basic Information List
Table Osiris Therapeutics Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Osiris Therapeutics Inc Regenerative Medicine Sales (K Units) and Growth Rate (2013-2018)
Figure Osiris Therapeutics Inc Regenerative Medicine Sales Market Share in EMEA (2013-2018)
Figure Osiris Therapeutics Inc Regenerative Medicine Revenue Market Share in EMEA (2013-2018)
Table Japan Tissue Engineering Co Regenerative Medicine Basic Information List
Table Thermogenesis Corp Regenerative Medicine Basic Information List
Table Mesoblast, Inc Regenerative Medicine Basic Information List
Table Vertex Pharmaceuticals, Inc Regenerative Medicine Basic Information List
Table Organogenesis, Inc Regenerative Medicine Basic Information List
Table Nuvasive, Inc Regenerative Medicine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Regenerative Medicine
Figure Manufacturing Process Analysis of Regenerative Medicine
Figure Regenerative Medicine Industrial Chain Analysis
Table Raw Materials Sources of Regenerative Medicine Major Manufacturers in 2017
Table Major Buyers of Regenerative Medicine
Table Distributors/Traders List
Figure EMEA Regenerative Medicine Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Regenerative Medicine Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Regenerative Medicine Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Regenerative Medicine Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Regenerative Medicine Sales Market Share Forecast by Region (2018-2025)
Table EMEA Regenerative Medicine Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Regenerative Medicine Revenue Market Share Forecast by Region (2018-2025)
Table Europe Regenerative Medicine Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Regenerative Medicine Sales Market Share Forecast by Countries (2018-2025)
Table Europe Regenerative Medicine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Regenerative Medicine Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Regenerative Medicine Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Regenerative Medicine Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Regenerative Medicine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Regenerative Medicine Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Regenerative Medicine Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Regenerative Medicine Sales Market Share Forecast by Countries (2018-2025)
Table Africa Regenerative Medicine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Regenerative Medicine Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Regenerative Medicine Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Regenerative Medicine Sales Market Share Forecast by Type (2018-2025)
Table EMEA Regenerative Medicine Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Regenerative Medicine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources